Showing results (61-70 of 112) with videos related to
Sort By:
Pageof 12
International Journal of Oncology|August 13, 2008
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of casesM A Pantaleo, M Nannini, E Lopci, et al.Frontiers in Cell and Developmental Biology|June 28, 2021
Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy ApproachesNoemi Laprovitera, Irene Salamon, Francesco Gelsomino, et al.Journal of the National Cancer Institute|April 21, 2011
SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencingMaria A Pantaleo, Annalisa Astolfi, Valentina Indio, et al.Clinical Colorectal Cancer|June 19, 2013
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastasesGiovanni Brandi, Enrico Derenzini, Alfredo Falcone, et al.BMC Cancer|May 6, 2022
A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumorMaria A Pantaleo, Michael C Heinrich, Antoine Italiano, et al.Critical Reviews in Oncology/Hematology|June 7, 2025
Exploring the role of TERT in thyroid Cancer: A systematic reviewThais Maloberti, Andrea Repaci, Laura Poppi, et al.The Pharmacogenomics Journal|September 22, 2018
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumorGloria Ravegnini, Milena Urbini, Vittorio Simeon, et al.BMC Cancer|September 21, 2014
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST)Margherita Nannini, Annalisa Astolfi, Milena Urbini, et al.International Journal of Cancer|August 13, 2009
Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic targetMaria A Pantaleo, Annalisa Astolfi, Monica Di Battista, et al.International Journal of Molecular Sciences|February 25, 2023
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral CentreAntonio De Leo, Daniela Serban, Thais Maloberti, et al.Pageof 12